相关实验视频
Updated: Jun 29, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
用家用灰尘虫提取物进行过敏原免疫疗法的有效性,用于儿科支气管喘
Masaaki Hamada1, Keigo Saeki2, Ichiro Tanaka1
1Department of Pediatrics, Yao Municipal Hospital, Osaka, Japan.
Immunotherapy
|March 26, 2024
概括
与下舌免疫疗法 (SLIT) 相比,急诊室灰尘虫免疫疗法 (SCIT) 对儿科喘患者提供了更快的缓解. 通过SCIT,孩子们可以更早地停止长期控制药物.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 儿科肺病学 儿科肺病学
- 药物治疗 药物治疗
背景情况:
- 儿科支气管喘 (BA) 管理通常涉及长期控制药物治疗 (LTCP).
- 家庭灰尘虫 (HDM) 免疫疗法,包括皮下 (SCIT) 和舌下 (SLIT) 途径,是一种治疗选择.
- 对比不同免疫疗法途径的有效性对于优化儿科BA护理至关重要.
研究的目的:
- 为了比较急性皮下免疫疗法 (SCIT) 与使用标准化HDM提取物进行的舌下免疫疗法 (SLIT) 在患有支气管喘的儿科患者中的有效性.
- 确定在两个治疗组中实现无需长期控制药物治疗 (无LTCP) 的状态的时间.
主要方法:
- 一项为期3年的前性研究追踪了儿科BA治疗得分.
- 评估达到无LTCP状态的中位时间.
- 统计分析包括调整混因素和倾向得分匹配,以比较HDM SCIT和HDM SLIT组之间的结果.
主要成果:
- 接受急诊HDM SCIT的患者比接受HDM SLIT治疗的患者要早得多地实现了LTCP-free状态.
- 这些发现在调整混变量和使用倾向性得分匹配后仍然具有意义.
结论:
- 与HDM SLIT相比,Rush HDM SCIT在儿科BA患者中表现出治疗效果的更快开始.
- 这表明,急性SCIT可能是一种更有效的免疫疗法方法,用于在患有HDM过敏喘的儿童中实现药物独立.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Allergic Reactions
27.3K
Overview
27.3K
Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K

